Global Life Sciences
Overview
Featured News & Insights
0017
Contacts
Services
Advising on the full scope of regulatory, compliance and enforcement, litigation and transactional matters, we can offer you a holistic legal approach that will smooth your path as you navigate industry changes, technological advances, market demands and policy hurdles.
Regions
From high-profile transactions to regulatory issues and complex litigation, we collaborate across borders and disciplines to help our clients in more than 70 countries face challenges and embrace opportunities.

All Professionals
sort


Capabilities
- Antitrust and Competition
- Capital Markets
- Commercial Litigation and Disputes
- Emerging Companies and Venture Capital
- Environmental, Health, and Safety
- Food, Drug and Medical Device
- Global Arbitration, Trade and Advocacy
- Government Strategies
- Healthcare
- IP Litigation
- M&A
- Privacy and Cybersecurity
- Private Equity
- Product Liability and Mass Torts
- Technology
- Technology and Life Sciences Transactions
Related Resources
Related Blogs
News & Insights
Is my product a medical device? EU Court judgment clarifies that the test includes objective function and intended purpose, and provides guidance relevant to software and AI-enabled toolsAugust 31, 2026UK Looks To Modernize Medicines And Medical Device Regulation In The Era Of AIAugust 26, 2026Swiss MedTech 2026Tuesday, August 25, 2026CMS’ CY 2027 OPPS and PFS Proposed Rules Include Major Changes to Reimbursement for 340B Hospitals, Data Reporting, and Digital HealthAugust 24, 2026
GoodLifeSci
GoodLifeSci
Conferences
GoodLifeSci
Illinois Expands Attorney General Review of Healthcare TransactionsAugust 13, 2026Shifting Expectations: FDA Takes a First Step Toward Making GRAS Notifications MandatoryAugust 12, 2026The Evolving Global Landscape for Orphan Drug ExclusivityJuly 28, 2026OIG Signals Further Support for Manufacturer-Sponsored Testing Programs with Fourth Favorable Advisory OpinionJuly 8, 2026
Healthcare Update
Food, Drug and Medical Device Update
Global Life Sciences Update
Global Life Sciences Update
Recent ESG Developments in EuropeAugust 2026Through the Looking Glass: What WHA79 Reveals About the Future of Global Life SciencesAugust 2026Switzerland Expands Integrity Rules to Medical Devices: Key Compliance Implications for Medtech CompaniesAugust 2026When AI Changes the Deal: Rethinking Risk, Milestones, and Timing in Life Sciences M&AJuly 29, 2026
Sidley Life Sciences Briefing
Sidley Life Sciences Briefing
Sidley Life Sciences Briefing
Life Science Leader
Sidley Represents Rael in Its Strategic Investment from TowerBrook Capital PartnersAugust 24, 2026Sidley Represents Werewolf Therapeutics in Merger with Ambros Therapeutics and Concurrent US$150 Million Private PlacementAugust 21, 2026Sidley Represents SlateView Capital in Joint Venture Formation and Acquisition of Meadowbrook at Agoura Hills in Southern CaliforniaAugust 18, 2026Sidley Advises on Janus Living’s US$533.6 Million Public OfferingAugust 14, 2026
Announcements
Announcements
Announcements
Announcements
Managing IP Recognizes Sidley and 12 Lawyers in IP Stars 2026July 31, 2026Sidley Shortlisted in 16 Categories at the LMG Life Sciences Americas Awards 2026July 20, 2026Sidley Highly Ranked in Chambers USA 2026June 4, 2026Sidley Wins Seven “Firm of the Year” Recognitions at the China Business Law AwardsMay 29, 2026
Accolades
Accolades
Accolades
Accolades
Is my product a medical device? EU Court judgment clarifies that the test includes objective function and intended purpose, and provides guidance relevant to software and AI-enabled toolsAugust 31, 2026UK Looks To Modernize Medicines And Medical Device Regulation In The Era Of AIAugust 26, 2026CMS’ CY 2027 OPPS and PFS Proposed Rules Include Major Changes to Reimbursement for 340B Hospitals, Data Reporting, and Digital HealthAugust 24, 2026AI Collaborations – From Strategic License to Strategic AcquisitionJune 15, 2026
GoodLifeSci
GoodLifeSci
GoodLifeSci
GoodLifeSci
Renewed Market Optimism @ JPM 2026January 12, 2026What's Ahead for Life Sciences Dealmaking @ JPM 2026January 12, 2026Top 10 FDA Areas We Are Watching @ JPM 2026January 12, 2026Regulatory Considerations for the Next Wave of Development-Stage Transactions @ JPM 2026January 12, 2026
Videos
Videos
Videos
Videos






































